HR+/HER2- Breast Cancer

DBCOND0148150NeoplasmsSkin and Subcutaneous Tissue Diseases

HR+/HER2- Breast Cancer is a condition in DrugBank's curated disease hierarchy.

Also known as
HR+ HER2 Negative Breast Cancer · Hormone Receptor Positive HER-2 Negative Breast Cancer · Hormone Receptor Positive, HER2 Negative Breast Cancer · Breast Cancer (HR+HER2-) · HR+ HER2- breast cancer
Classified under

Resolves to

Vocabularies
MedDRA10085481UMLSC5442556

What you can answer from here — as of September 29, 2026

73Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which drugs are in clinical trials for HR+/HER2- Breast Cancer, in which phases, and against which targets?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In